Actively Recruiting

Phase 2
Age: 18Years +
All Genders
NCT05617716

Spine Radiosurgery for Symptomatic Metastatic Neoplasms

Led by University of Oklahoma · Updated on 2025-10-20

240

Participants Needed

2

Research Sites

211 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The purpose of this study is to compare three types of radiation therapy for cancer that has spread to the spine. The two types of radiation therapy used in this trial are External Beam Radiation Therapy (EBRT) and Stereotactic Body Radiation Therapy (SBRT). EBRT delivers tightly targeted radiation beams from outside the body. SBRT is a specialized type of radiation therapy that allows high doses of radiation to small targets. This study will include standard dose SBRT and higher dose SBRT. Each participant will be randomly assigned to either EBRT, standard dose SBRT, or higher dose SBRT.

CONDITIONS

Official Title

Spine Radiosurgery for Symptomatic Metastatic Neoplasms

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Participant must have histologic confirmation of malignancy with spinal metastatic disease confirmed by imaging
  • No prior therapies for this disease, including previous radiation therapy overlapping the spine treatment area
  • Age greater than 18 years
  • Life expectancy of at least 3 months as documented by the investigator
  • Worst pain score less than 2 of 10 on the Brief Pain Inventory
  • No intention to change pain medications on the first day of SBRT
  • Spinal Instability score (SINS) less than or equal to 12
  • Candidate for spine SBRT as determined by Radiation Oncology
  • Ability and willingness to sign informed consent
Not Eligible

You will not qualify if you...

  • Receiving any other investigational agents
  • Prognosis less than 3 months
  • Uncontrolled illness such as active infection, symptomatic heart failure, unstable angina, cardiac arrhythmia, or psychiatric/social issues limiting compliance
  • Pregnant or nursing
  • Unable to receive MRI of the spine
  • Spinal Instability in Neoplasia score (SINS) greater than or equal to 12
  • Previous stereotactic radiosurgery overlapping the current treatment field
  • More than 3 consecutive vertebral bodies in the SBRT treatment volume
  • Not a candidate for SBRT per Radiation Oncology
  • Known primary cancer with estimated median survival 3 months or less
  • Unknown primary cancer
  • Brief Pain Inventory score greater than 2
  • Previous radiation therapy involving the intended SBRT treatment field
  • Previous spinal surgery involving the SBRT target volume (biopsy excluded)
  • Neurological deficits from malignant cauda equina or epidural spinal cord compression

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Johns Hopkins University Hospitals

Baltimore, Maryland, United States, 21287

Active, Not Recruiting

2

OU Health Stephenson Cancer Center

Oklahoma City, Oklahoma, United States, 73117

Actively Recruiting

Loading map...

Research Team

L

Lead Onco Nurse

CONTACT

S

Shearwood McClelland III, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here